27-Jan-2026
Download PDF
Wockhardt
Pursuant to Regulation 30 0f Listing Regulations please find enclosed Press Release- "Wockhardts Fifth Novel Antibiotic Foviscu (WCK 4282) Matches Gold Standard Meropenem in pivotal Phase 3 Trial as First-Line Therapies Fail Against Rising Resistance.":
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
